Hemab Therapeutics Holdings, Inc. Common Stock (COAG)
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Hemab Therapeutics Holdings, Inc. Common Stock (COAG) is listed on Nasdaq, where it has traded since May 1, 2026.
- Listed On
- Nasdaq
- Listed Since
- May 1, 2026
- Market Cap
- $1.4B
About Hemab Therapeutics Holdings, Inc. Common Stock
Hemab Therapeutics Holdings Inc is a clinical-stage biotechnology company developing therapies for the treatment of blood coagulation disorders. It focuses on discovering, developing, and commercializing treatments for conditions such as Glanzmann thrombasthenia, Factor VII deficiency, and von Willebrand disease. Its flagship candidate, sutacimig (HMB-001), is a bispecific antibody currently in clinical trials for the prophylactic treatment of Glanzmann thrombasthenia and Factor VII deficiency. The company has one operating segment, engaged in the research and development of prophylactic therapeutics for bleeding disorders.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 52 institutions reported holding COAG, with 36.2 million shares worth $1.3 billion in aggregate. The largest reported holder was RA Capital Management,, with 7.8 million shares worth $286.8 million. Of the 5 largest holders listed below, all 5 opened new positions in COAG during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| RA Capital Management, | 7,808,627 | $287M | New position |
| Novo Holdings a/S | 4,180,550 | $154M | New position |
| FMR | 3,697,837 | $136M | New position |
| Capital Group | 3,603,876 | $132M | New position |
| Deep Track Capital | 3,602,093 | $132M | New position |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is COAG?
Hemab Therapeutics Holdings, Inc. Common Stock (COAG) is listed on Nasdaq, where it has traded since May 1, 2026.
Who are the largest institutional holders of COAG?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of COAG were RA Capital Management,, Novo Holdings a/S and FMR.
How many institutions own COAG?
52 institutions reported a position in COAG for the quarter ended June 30, 2026, worth $1.3 billion in total.
Did institutions buy or sell COAG last quarter?
Of the 5 largest reported holders, all 5 opened new positions in COAG during the quarter. Every reported holder and its change is on the SentiSense ownership page for COAG.
Every reported institutional holder, plus insider and congressional trades in COAG, on SentiSense.